165 related articles for article (PubMed ID: 35922814)
1. Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients.
Lim ZL; Ho PJ; Khng AJ; Yeoh YS; Ong ATW; Tan BKT; Tan EY; Tan SM; Lim GH; Lee JA; Tan VK; Hu J; Li J; Hartman M
BMC Med; 2022 Aug; 20(1):239. PubMed ID: 35922814
[TBL] [Abstract][Full Text] [Related]
2. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
3. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
4. Associations between Pre-Diagnostic Physical Activity with Breast Cancer Characteristics and Survival.
Lim ZL; Lim GH; Ho PJ; Khng AJ; Yeoh YS; Ong ATW; Tan BKT; Tan EY; Tan SM; Tan VK; Li J; Hartman M
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406528
[TBL] [Abstract][Full Text] [Related]
5. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
6. Multi-level determinants of breast cancer screening among Malay-Muslim women in Singapore: a sequential mixed-methods study.
Goh SA; Lee JK; Seh WY; Ho EQY; Hartman M; Chou C; Wong ML
BMC Womens Health; 2022 Sep; 22(1):383. PubMed ID: 36123600
[TBL] [Abstract][Full Text] [Related]
7. Predictors of breast cancer screening behavior in women with a strong family history of the disease.
Price MA; Butow PN; Charles M; Bullen T; Meiser B; McKinley JM; McLachlan SA; Phillips KA; ;
Breast Cancer Res Treat; 2010 Nov; 124(2):509-19. PubMed ID: 20364401
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer and breast cancer screening use-beliefs and behaviours in a nationwide study in Malaysia.
Tan MM; Jamil ASA; Ismail R; Donnelly M; Su TT
BMC Public Health; 2023 Jul; 23(1):1319. PubMed ID: 37430228
[TBL] [Abstract][Full Text] [Related]
9. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
FH01 collaborative teams
Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
[TBL] [Abstract][Full Text] [Related]
10. Unmet Social Needs and Breast Cancer Screening Utilization and Stage at Presentation.
Goel N; Lubarsky M; Hernandez AE; Benck K; Lee E; Kesmodel S; Knaul F; Kobetz E; Anderson BO
JAMA Netw Open; 2024 Feb; 7(2):e2355301. PubMed ID: 38353954
[TBL] [Abstract][Full Text] [Related]
11. Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry.
Ritvo P; Edwards SA; Glendon G; Mirea L; Knight JA; Andrulis IL; Chiarelli AM
BMC Public Health; 2012 Jul; 12():518. PubMed ID: 22788119
[TBL] [Abstract][Full Text] [Related]
12. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
14. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
15. Analyzing factors associated with decisional stage of adopting breast cancer screening among Korean American women using precaution adoption process model.
Jin SW; Lee J; Yun Lee H
Ethn Health; 2021 Apr; 26(3):431-447. PubMed ID: 30326735
[No Abstract] [Full Text] [Related]
16. Screening mammography: a cross-sectional study to compare characteristics of women aged 40 and older from the deep South who are current, overdue, and never screeners.
Lopez ED; Khoury AJ; Dailey AB; Hall AG; Chisholm LR
Womens Health Issues; 2009; 19(6):434-45. PubMed ID: 19879455
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Screening in Semi-Rural Malaysia: Utilisation and Barriers.
Mohan D; Su TT; Donnelly M; Hoe WMK; Schliemann D; Tan MM; Reidpath D; Taib NA; Allotey P
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886015
[TBL] [Abstract][Full Text] [Related]
18. Effect of mammography screening and sociodemographic factors on stage of female breast cancer at diagnosis in New South Wales.
Tong S; Warner-Smith M; McGill S; Roder D; Currow D
Aust Health Rev; 2020 Dec; 44(6):944-951. PubMed ID: 33198883
[TBL] [Abstract][Full Text] [Related]
19. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
20. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
